ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis
USA - NASDAQ:KIDS - US68752L1008 - Common Stock
16.4 USD
+0.03 (+0.18%)
16.4 USD
0 (0%)
Overall KIDS gets a fundamental rating of 3 out of 10. We evaluated KIDS against 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of KIDS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, KIDS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
KIDS had negative earnings in the past year.
KIDS had a negative operating cash flow in the past year.
In the past 5 years KIDS reported 4 times negative net income.
KIDS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
KIDS's Return On Assets of -9.24% is fine compared to the rest of the industry. KIDS outperforms 62.43% of its industry peers.
With a decent Return On Equity value of -13.06%, KIDS is doing good in the industry, outperforming 64.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.24% | ||
| ROE | -13.06% | ||
| ROIC | N/A |
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 71.73%, KIDS belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
In the last couple of years the Gross Margin of KIDS has remained more or less at the same level.
KIDS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
2. Health
2.1 Basic Checks
KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KIDS has been increased compared to 1 year ago.
The number of shares outstanding for KIDS has been increased compared to 5 years ago.
KIDS has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.72, we must say that KIDS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.72, KIDS is in line with its industry, outperforming 57.14% of the companies in the same industry.
KIDS has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
KIDS's Debt to Equity ratio of 0.28 is in line compared to the rest of the industry. KIDS outperforms 52.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.72 |
ROIC/WACCN/A
WACC8.48%
2.3 Liquidity
A Current Ratio of 7.40 indicates that KIDS has no problem at all paying its short term obligations.
The Current ratio of KIDS (7.40) is better than 87.30% of its industry peers.
KIDS has a Quick Ratio of 3.52. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of KIDS (3.52) is better than 70.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.4 | ||
| Quick Ratio | 3.52 |
3. Growth
3.1 Past
KIDS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.54%.
KIDS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.90%.
The Revenue has been growing by 23.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.06%
Revenue 1Y (TTM)19.9%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%12.23%
3.2 Future
KIDS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.90% yearly.
Based on estimates for the next years, KIDS will show a quite strong growth in Revenue. The Revenue will grow by 13.05% on average per year.
EPS Next Y2.38%
EPS Next 2Y11.52%
EPS Next 3Y12.64%
EPS Next 5Y7.9%
Revenue Next Year15.23%
Revenue Next 2Y13.84%
Revenue Next 3Y13.25%
Revenue Next 5Y13.05%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
KIDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KIDS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
KIDS's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.52%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
KIDS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.4
+0.03 (+0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.17%
Inst Owner Change-1.6%
Ins Owners5.07%
Ins Owner Change0.88%
Market Cap411.15M
Revenue(TTM)227.41M
Net Income(TTM)-45.61M
Analysts83.08
Price Target26.81 (63.48%)
Short Float %6.4%
Short Ratio6.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.35%
Min EPS beat(2)-89.58%
Max EPS beat(2)2.89%
EPS beat(4)1
Avg EPS beat(4)-50.67%
Min EPS beat(4)-115.9%
Max EPS beat(4)2.89%
EPS beat(8)3
Avg EPS beat(8)-27.23%
EPS beat(12)6
Avg EPS beat(12)-15.09%
EPS beat(16)9
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-3.13%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-2.47%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.82%
Revenue beat(16)4
Avg Revenue beat(16)-1.04%
PT rev (1m)-22.36%
PT rev (3m)-27.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.36%
EPS NY rev (1m)2.65%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)-1.86%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-1.65%
Revenue NY rev (3m)-1.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.18 | ||
| P/tB | 2.47 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.95
EYN/A
EPS(NY)-1.23
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS9.07
BVpS13.93
TBVpS6.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.24% | ||
| ROE | -13.06% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.73% | ||
| FCFM | N/A |
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 74.39% | ||
| Cap/Sales | 6.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.4 | ||
| Quick Ratio | 3.52 | ||
| Altman-Z | 1.72 |
F-Score3
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.06%
EPS Next Y2.38%
EPS Next 2Y11.52%
EPS Next 3Y12.64%
EPS Next 5Y7.9%
Revenue 1Y (TTM)19.9%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%12.23%
Revenue Next Year15.23%
Revenue Next 2Y13.84%
Revenue Next 3Y13.25%
Revenue Next 5Y13.05%
EBIT growth 1Y-10.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.56%
EBIT Next 3Y50.18%
EBIT Next 5Y35.85%
FCF growth 1Y86.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.73%
OCF growth 3YN/A
OCF growth 5YN/A
ORTHOPEDIATRICS CORP / KIDS FAQ
What is the fundamental rating for KIDS stock?
ChartMill assigns a fundamental rating of 3 / 10 to KIDS.
What is the valuation status of ORTHOPEDIATRICS CORP (KIDS) stock?
ChartMill assigns a valuation rating of 0 / 10 to ORTHOPEDIATRICS CORP (KIDS). This can be considered as Overvalued.
What is the profitability of KIDS stock?
ORTHOPEDIATRICS CORP (KIDS) has a profitability rating of 2 / 10.
What is the financial health of ORTHOPEDIATRICS CORP (KIDS) stock?
The financial health rating of ORTHOPEDIATRICS CORP (KIDS) is 4 / 10.
How sustainable is the dividend of ORTHOPEDIATRICS CORP (KIDS) stock?
The dividend rating of ORTHOPEDIATRICS CORP (KIDS) is 0 / 10 and the dividend payout ratio is 0%.